What is the Share Price of BANKA BIOLOO LIMITED?

BANKA BIOLOO LIMITED share price is ₹95.51 As on 10 March, 2025|20:04

Home
>
Stocks
>
BANKA BIOLOO LIMITED

BANKA BIOLOO LIMITED Share Price

Q: What is the Market Cap of BANKA BIOLOO LIMITED?

The Market Cap of BANKA BIOLOO LIMITED is ₹120 As on 10 March, 2025|20:04

Q: What is PE Ratio of BANKA BIOLOO LIMITED?

The P/E ratio of BANKA BIOLOO LIMITED is 20.2 As on 10 March, 2025|20:04

Q: What is PB Ratio of BANKA BIOLOO LIMITED?

The PB ratio of BANKA BIOLOO LIMITED is 2.94 As on 10 March, 2025|20:04

₹ 95.51 +14.19 (17.45%)
Updated on 10-03-2025 6:04 PM

Stock Rating

NSE

Pros 2

Cons 6

BANKA BIOLOO LIMITED Price Performance

Day's Low
₹90.1

Day's High
₹97.56

₹ 95.51

52-w low
₹56.99

52-w high
₹143.9

95.51

Day's open
₹93
Previous close
₹81.32
VWAP
₹95.3
Lower price band
₹65.05
Upper price band
₹97.58

Today's Market Action

The last traded share price of BANKA BIOLOO LIMITED was 95.51 up by 17.45% on the NSE. The total volume of shares on NSE and BSE combined was 407,344 shares. Its total combined turnover was Rs 3.88 crores.

BANKA BIOLOO LIMITED Medium and Long Term Market Action

BANKA BIOLOO LIMITED hit a 52-week high of 143.9 on 02-09-2024 and a 52-week low of 56.99 on 03-03-2025. The stock price of BANKA BIOLOO LIMITED is up by 3% over the last one month. It is down by -14.34% over the last one year. Don't forget to check the full stock price history in the table below.

BANKA BIOLOO LIMITED Fundamentals

Market Cap (Cr): 120
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

BANKA BIOLOO LIMITED Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

BANKA BIOLOO LIMITED Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About BANKA BIOLOO LIMITED

Data not available.

BANKA BIOLOO LIMITED FAQ's

What is Share Price of BANKA BIOLOO LIMITED?

What is the Market Cap of BANKA BIOLOO LIMITED?

What is PE Ratio of BANKA BIOLOO LIMITED?

What is PB Ratio of BANKA BIOLOO LIMITED?

What is the CAGR of BANKA BIOLOO LIMITED?

How to Buy BANKA BIOLOO LIMITED Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 104.82% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Momentum Strength
The stock is currently exhibiting weak momentum, & is showing weak relative strength.
Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Interest Coverage
The company has a very low Interest coverage ratio of 1.68 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 74.37 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 290 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(10/03/2025)

107

Margin of Safety Index: Very High

50.00%

50.00% People are bullish about BANKA BIOLOO LIMITED

50.00%

50.00 % People are bearish about BANKA BIOLOO LIMITED

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %